World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
60
Citations
15143
World Ranking
11828
National Ranking
215

Michael Huber publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Michael Huber sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 233 publications — 62nd percentile

62% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Michael Huber D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Michael Huber sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 60 D-Index — 41st percentile

41% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Michael Huber is affiliated with the University of Zurich in Switzerland and has a body of research primarily focused in the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their scholarly output includes 58 publications in Medicine and 31 in Biochemistry, Genetics and Molecular Biology, reflecting an interdisciplinary approach to biomedical sciences.

Their research extends to several subfields including Immunology, Molecular Biology, Public Health, Environmental and Occupational Health, Hematology, and Cell Biology. This range indicates a comprehensive engagement with both fundamental biological processes and applied medical sciences.

Huber's work encompasses a variety of key topics such as:

  • Mast cells and histamine
  • Chronic Myeloid Leukemia Treatments
  • Palliative Care and End-of-Life Issues
  • Monoclonal and Polyclonal Antibodies Research
  • Endoplasmic Reticulum Stress and Disease
  • Chronic Lymphocytic Leukemia Research
  • PI3K/AKT/mTOR signaling in cancer

Frequent collaborators include Thomas Wilhelm, Mirle Schemionek, Jörg B. Schulz, Sandro Capellmann, and Arno Reich, indicating active cooperation with researchers who contribute across multiple publications. This collaboration network supports interdisciplinary and translational research efforts.

Huber's publications have appeared in notable venues such as:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • American Journal of Respiratory and Critical Care Medicine
  • Journal of Pain and Symptom Management
  • Translational Stroke Research
  • European Journal of Immunology

Selected recent papers include:

  • "Pharmacological induction of selective endoplasmic reticulum retention as a strategy for cancer therapy" (2020, Nature Communications)
  • "Microglial-specific depletion of TAK1 is neuroprotective in the acute phase after ischemic stroke" (2020, Journal of Molecular Medicine)
  • "Erythropoietin Abrogates Post-Ischemic Activation of the NLRP3, NLRC4, and AIM2 Inflammasomes in Microglia/Macrophages in a TAK1-Dependent Manner" (2021, Translational Stroke Research)
  • "Increased Post-Hypoxic Oxidative Stress and Activation of the PERK Branch of the UPR in Trap1-Deficient Drosophila melanogaster Is Abrogated by Metformin" (2021, International Journal of Molecular Sciences)
  • "Therapeutic inhibition of FcγRIIb signaling targets leukemic stem cells in chronic myeloid leukemia" (2020, Leukemia)

Best Publications

  • Broad neutralization coverage of HIV by multiple highly potent antibodies

    Laura M. Walker;Michael Huber;Michael Huber;Katie J. Doores;Katie J. Doores;Emilia Falkowska;Emilia Falkowska

  • CD14 is required for MyD88-independent LPS signaling

    Zhengfan Jiang;Philippe Georgel;Xin Du;Louis Shamel

  • Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies

    Alexandra Trkola;Herbert Kuster;Peter Rusert;Beda Joos

  • Progressive derangement of periinfarct viable tissue in ischemic stroke.

    W.-D. Heiss;M. Huber;G. R. Fink;K. Herholz

  • Monomeric IgE stimulates signaling pathways in mast cells that lead to cytokine production and cell survival.

    Janet Kalesnikoff;Michael Huber;Vivian Lam;Jacqueline E Damen

  • Broadly Neutralizing Monoclonal Antibodies 2F5 and 4E10 Directed against the Human Immunodeficiency Virus Type 1 gp41 Membrane-Proximal External Region Protect against Mucosal Challenge by Simian-Human Immunodeficiency Virus SHIVBa-L

    Ann J. Hessell;Eva G. Rakasz;David M. Tehrani;Michael Huber

  • IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells

    Shafaqat Ali;Michael Huber;Christian Kollewe;Stephan C. Bischoff

  • The src homology 2-containing inositol phosphatase (SHIP) is the gatekeeper of mast cell degranulation

    Michael Huber;Cheryl D. Helgason;Jacqueline E. Damen;Ling Liu

  • Proteasome inhibition by lipofuscin/ceroid during postmitotic aging of fibroblasts.

    Nicolle Sitte;Michael Huber;Tilman Grune;Axel Ladhoff

  • Phosphatidylinositol (3,4,5)P3 Is Essential but Not Sufficient for Protein Kinase B (PKB) Activation; Phosphatidylinositol (3,4)P2 Is Required for PKB Phosphorylation at Ser-473: STUDIES USING CELLS FROM SH2-CONTAINING INOSITOL-5-PHOSPHATASE KNOCKOUT MICE *

    Michael P. Scheid;Michael Huber;Jacqueline E. Damen;Michael Hughes

  • Adenosine and cAMP are potent inhibitors of the NF‐κB pathway downstream of immunoreceptors

    Susanna Minguet;Michael Huber;Lisa Rosenkranz;Wolfgang W. A. Schamel

  • R-form LPS, the master key to the activation of TLR4/MD-2-positive cells

    Michael Huber;Christoph Kalis;Simone Keck;Zhengfan Jiang

  • An EF hand mutation in Stim1 causes premature platelet activation and bleeding in mice

    Johannes Grosse;Attila Braun;David Varga-Szabo;Niklas Beyersdorf

  • Determinants of HIV-1 broadly neutralizing antibody induction

    Peter Rusert;Roger D Kouyos;Claus Kadelka;Hanna Ebner

  • Characterization of a 100-kilodalton binding protein for the six serotypes of coxsackie B viruses.

    U R de Verdugo;H C Selinka;M Huber;B Kramer

  • SHIP Negatively Regulates IgE + Antigen-Induced IL-6 Production in Mast Cells by Inhibiting NF-κB Activity

    Janet Kalesnikoff;Nicole Baur;Michael Leitges;Michael R. Hughes

  • Lipopolysaccharide sensing an important factor in the innate immune response to Gram-negative bacterial infections: Benefits and hazards of LPS hypersensitivity

    Marina A. Freudenberg;Sandrine Tchaptchet;Simone Keck;György Fejer

  • Humoral immunity to HIV-1: neutralization and beyond.

    M. Huber;A. Trkola

  • Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.

    Idoia Busnadiego;Sonja Fernbach;Marie O. Pohl;Umut Karakus

  • Protein Kinase C-δ Is a Negative Regulator of Antigen-Induced Mast Cell Degranulation

    Michael Leitges;Kerstin Gimborn;Winfried Elis;Janet Kalesnikoff

Frequent Co-Authors

Alexandra Trkola
Alexandra Trkola University of Zurich
Jürg Böni
Jürg Böni University of Zurich
Dennis R. Burton
Dennis R. Burton Scripps Research Institute
Marina A. Freudenberg
Marina A. Freudenberg University of Freiburg
Michael Reth
Michael Reth University of Freiburg
Dietrich Keppler
Dietrich Keppler German Cancer Research Center
Huldrych F. Günthard
Huldrych F. Günthard University of Zurich
Stefan Schmutz
Stefan Schmutz BOKU University
Gerald Krystal
Gerald Krystal BC Cancer Agency
Michael Leitges
Michael Leitges University of Oslo

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Students interested in biology and biochemistry often explore related career pathways in healthcare, research, and medical administration. For those looking to advance quickly, there are flexible online degrees and certification options that can open new doors in the medical field.

One route is pursuing an MBA in healthcare management. If you are cost-conscious, consider exploring the cheapest online mba healthcare programs, which offer leadership and business skills tailored to the medical sector.

Another prominent option is becoming a certified medical coder or biller. Understanding the differences between CPC and CCS certifications is crucial; the medical coding certification you choose can significantly impact your job responsibilities and earning potential.

Many biology graduates ask, how much do medical coders make? Salaries are competitive, especially for those with advanced certifications, and the profession offers steady employment opportunities.

For an in-depth look at future prospects, check out the medical coding job outlook. The demand for skilled professionals is expected to grow as the healthcare industry expands, making this a promising pathway for science and biochemistry majors seeking rewarding careers.

Best Scientists Citing Michael Huber

Trending Scientists

Recently Published Articles